14. Sep. 2023
Reaktion von Genentech
2yThank you for leaving us a review. Within the context of an evolving healthcare landscape, we’re evaluating our operations to ensure we remain well-positioned to meet the needs of patients today and deliver on our pipeline of new medicines in the future. While adjustment in process is sometimes needed in order to remain agile, we are grateful for our employees and are sorry to hear if you did not feel this along any part of your time here. Thank you for the 6+ years of dedication to our mission of bringing breakthrough medicines to patients.